Diabetes Insights from Large Human Islet Study
Researchers at Vanderbilt University Medical Center have made a groundbreaking discovery about diabetes, a disease affecting over 12% of Americans. The study, released on May 12, 2026, sheds new…
Wellness Bio Radar
Breaking health news, regulatory updates and important developments in medical and wellness science.
69 articlesResearchers at Vanderbilt University Medical Center have made a groundbreaking discovery about diabetes, a disease affecting over 12% of Americans. The study, released on May 12, 2026, sheds new…
Researchers are tackling the challenge of cardiovascular disease, a major global health burden, by developing advanced 3D heart models. This breakthrough comes as many preclinical systems struggle to…
Yuki Noguchi reports on a woman battling pancreatic cancer, a disease known for its low survival rate. The story aired on Morning Edition on May 12, 2026. Pancreatic cancer is often diagnosed late,…
P1: A significant recall of chocolate products has been announced due to potential health risks. The recall affects various brands and is a response to concerns raised by health authorities. P2: The…
P1: Body Mass Index (BMI) is a widely recognized tool used to evaluate an individual’s health based on their weight relative to height. This formula is often employed by healthcare professionals to…
Two teenagers managing both type 1 diabetes and obesity experienced positive results with GLP-1 receptor agonists. These patients, requiring daily insulin, demonstrated weight loss and a decreased…
A hantavirus outbreak on the MV Hondius cruise ship is evolving. Health officials now suspect the virus is spreading between passengers. The outbreak began recently while the ship was at sea. The…
A new beverage is gaining attention for its potential health benefits. It focuses on supporting a healthy gut microbiome while providing hydration. Health experts suggest this drink could become a…
New medications are gaining attention for their impact on weight management. These drugs, called GLP-1 receptor agonists, were initially developed for diabetes. Now, they’re being widely discussed…